Abbvie Inc (NYSE:ABBV)
| 106.89 Delayed Data As of 4:00pm ET |  +0.49 / +0.46%Today’s Change | 79.11 Today|||52-Week Range 121.53 | -0.24% Year-to-Date |
Latest ABBV News | Press Releases
| AbbVie (ABBV) Files for Skyrizi in Crohn's Disease With FDA 12:07pm / Zacks.com - Paid Partner Content | Calamos Growth and Income Portfolio Buys AbbVie Inc, Sells Fortive Corp, Vertex Pharmaceuticals ... Sep 18 / GuruFocus News - Paid Partner Content |
| Biogen's (BIIB) Lucentis BioSimilar Byooviz Gets FDA Approval 10:32am / Zacks.com - Paid Partner Content | AbbVie's Pain Is Sanofi's and Regeneron's Gain Sep 18 / MotleyFool.com - Paid Partner Content |
| AbbVie (ABBV) Stock Moves -1.23%: What You Should Know Sep 20 / Zacks.com - Paid Partner Content | 5 Berkshire Hathaway Stocks in Downtrends Sep 17 / GuruFocus News - Paid Partner Content |
| Sunflower Bank, N.A. Buys S&P 500 ETF TRUST ETF, Procter & Gamble Co, JPMorgan ... Sep 20 / GuruFocus News - Paid Partner Content | 4 Berkshire Hathaway Stocks in Downtrends Sep 17 / GuruFocus News - Paid Partner Content |
| Is AbbVie a Bad News Buy? Sep 19 / MotleyFool.com - Paid Partner Content | Why BeiGene's Shares Jumped on Friday Sep 17 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 106.40 |
| Today’s open | 106.38 |
| Day’s range | 106.38 - 107.40 |
| Volume | 6,258,176 |
| Average volume (3 months) | 6,902,952 |
| Market cap | $190.4B |
Data as of 4:00pm ET, 09/21/2021
Growth & Valuation
| Earnings growth (last year) | -48.39% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +3.80% |
| Revenue growth (last year) | +37.69% |
| P/E ratio | 29.0 |
| Price/Sales | 3.91 |
| Price/Book | 14.54 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | +0.21 | +0.25% |
| MRKMerck | +0.01 | +0.01% |
| AZNAstraZeneca | +0.61 | +1.04% |
| NVONovo Nordisk | +2.13 | +2.14% |
Data as of 4:09pm ET, 09/21/2021
Financials
| Next reporting date | October 29, 2021 |
| EPS forecast (this quarter) | $3.23 |
| Annual revenue (last year) | $45.8B |
| Annual profit (last year) | $4.6B |
| Net profit margin | 9.95% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters North Chicago, Illinois |
Forecasts
